Work

Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells

Year: 2022
Type: article
Abstract: Cancer stem cells (CSCs) are thought to be responsible for cancer initiation, growth, recurrence, metastasis, and drug resistance. 1 Therefore, targeting CSCs is an effective therapeutic approach for cancer. 2 However, there are few CSC-specific targets with functional extracellular domains for the development of antibody drugs. 3 Our published paper demonstrated that transmembrane 4 L six family member 1 (TM4SF1) coupled discoidin domain receptor tyrosine kinase 1 (DDR1) under collagen I stimulation activated JAK2-STAT3 signaling. This noncanonical DDR1 signaling sustained the manifestation of CSC traits by inducing SOX2 and NANOG expression and drove multiorgan metastases. 4
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,990
OpenAlex ID: W4306153830
FWCI: 2.147
Cites: 5
Cited by: 24
Related to: 10